Your browser doesn't support javascript.
loading
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data.
Delhomme, Tiffany M; Avogbe, Patrice H; Gabriel, Aurélie A G; Alcala, Nicolas; Leblay, Noemie; Voegele, Catherine; Vallée, Maxime; Chopard, Priscilia; Chabrier, Amélie; Abedi-Ardekani, Behnoush; Gaborieau, Valérie; Holcatova, Ivana; Janout, Vladimir; Foretová, Lenka; Milosavljevic, Sasa; Zaridze, David; Mukeriya, Anush; Brambilla, Elisabeth; Brennan, Paul; Scelo, Ghislaine; Fernandez-Cuesta, Lynnette; Byrnes, Graham; Calvez-Kelm, Florence L; McKay, James D; Foll, Matthieu.
Afiliação
  • Delhomme TM; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Avogbe PH; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Gabriel AAG; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Alcala N; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Leblay N; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Voegele C; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Vallée M; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Chopard P; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Chabrier A; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Abedi-Ardekani B; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Gaborieau V; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Holcatova I; Institute of Hygiene and Epidemiology, Charles University, 1st Faculty of Medicine, 116 36 Prague, Czech Republic.
  • Janout V; Faculty of Health Sciences, Palacky University, 775 15 Olomouc, Czech Republic.
  • Foretová L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic.
  • Milosavljevic S; International Organization for Cancer Prevention and Research (IOCPR), 11070 Belgrade, Serbia.
  • Zaridze D; Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, The Russian Federation.
  • Mukeriya A; Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, The Russian Federation.
  • Brambilla E; Centre Hospitalier Universitaire de Grenoble Département d'Anatomie et Cytologie Pathologiques, CS 10217 38043 Grenoble, France.
  • Brennan P; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Scelo G; Genetic Epidemiology Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Fernandez-Cuesta L; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Byrnes G; Section of Environment and Radiation, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Calvez-Kelm FL; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • McKay JD; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
  • Foll M; Genetic Cancer Susceptibility Group, Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 150 cours Albert Thomas, 69008 Lyon, France.
NAR Genom Bioinform ; 2(2): lqaa021, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32363341
ABSTRACT
The emergence of next-generation sequencing (NGS) has revolutionized the way of reaching a genome sequence, with the promise of potentially providing a comprehensive characterization of DNA variations. Nevertheless, detecting somatic mutations is still a difficult problem, in particular when trying to identify low abundance mutations, such as subclonal mutations, tumour-derived alterations in body fluids or somatic mutations from histological normal tissue. The main challenge is to precisely distinguish between sequencing artefacts and true mutations, particularly when the latter are so rare they reach similar abundance levels as artefacts. Here, we present needlestack, a highly sensitive variant caller, which directly learns from the data the level of systematic sequencing errors to accurately call mutations. Needlestack is based on the idea that the sequencing error rate can be dynamically estimated from analysing multiple samples together. We show that the sequencing error rate varies across alterations, illustrating the need to precisely estimate it. We evaluate the performance of needlestack for various types of variations, and we show that needlestack is robust among positions and outperforms existing state-of-the-art method for low abundance mutations. Needlestack, along with its source code is freely available on the GitHub platform https//github.com/IARCbioinfo/needlestack.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article